is zepbound a glp-1 drug How It Works: Dual GLP-1/GIP Action Weight-Loss Drug Zepbound Now in
Description
Combining weight loss drugs without medical supervision is not recommended
In a study of Wegovy in people with or without type 2 diabetes, people taking 1.7 mg and 2.4 mg dosages lost an average of 2% of their body weight after one month
Kosowska A, Gallego-Colon E, Garczorz W, Klych-Ratuszny A, Aghdam MR, Woz Niak M, et al
Some real world data shows promise that a few may maintain their full weight loss for at least one year after stopping GLP-1 therapy, especially if they continue with lifestyle improvements
